Puretech Health Stock Price, News & Analysis (LON:PRTC)

GBX 170.85 +0.85 (+0.50 %)
(As of 02/23/2018 03:46 AM ET)
Previous CloseGBX 172.25
Today's RangeGBX 170.85 - GBX 170.85
52-Week RangeGBX 110 - GBX 183.50
Volume285 shs
Average Volume90,904 shs
Market Capitalization£404.57 million
P/E Ratio-899.21
Dividend YieldN/A
BetaN/A

About Puretech Health (LON:PRTC)

Puretech Health logoPureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets. This segment includes subsidiary companies, which include Vedanta Biosciences, Inc., Gelesis, Inc., Akili Interactive Lab, Inc., Tal Medical, Inc., Karuna Pharmaceuticals, Inc., Entrega Inc. and Follica Incorporated. Businesses in the project phase businesses segment are those whose activities are focused on financing, sourcing and creating new product candidates and newly created businesses whose technologies are in the process of validation. This segment includes subsidiary companies, which include The Sync Project Inc., Sonde Health, Inc., Commense Inc., Alivio Therapeutics, Inc., Vor Biopharma Inc., Enlight Biosciences, LLC, Mandara Sciences, LLC and Knode Inc.

Receive PRTC News and Ratings via Email

Sign-up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorHealthcare
SymbolLON:PRTC
CUSIPN/A
Phone+1-617-4822333

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-899.210526315789
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSGBX (0.19)
Net IncomeN/A
Net Margins-10,126.32%
Return on Equity-53.32%
Return on Assets-47.28%

Miscellaneous

EmployeesN/A
Outstanding Shares237,430,000

Puretech Health (LON:PRTC) Frequently Asked Questions

What is Puretech Health's stock symbol?

Puretech Health trades on the London Stock Exchange (LON) under the ticker symbol "PRTC."

Where is Puretech Health's stock going? Where will Puretech Health's stock price be in 2018?

5 brokers have issued 12 month target prices for Puretech Health's stock. Their forecasts range from GBX 225 to GBX 313. On average, they expect Puretech Health's share price to reach GBX 260.20 in the next twelve months. View Analyst Ratings for Puretech Health.

Who are some of Puretech Health's key competitors?

Who are Puretech Health's key executives?

Puretech Health's management team includes the folowing people:

  • Joichi Ito, Chairman of the Board (Age 51)
  • Daphne Zohar, Chief Executive Officer, Co-Founder, Director
  • Robert S. Langer Jr., Co-Founder, Non-Executive Director (Age 68)
  • Bennett M. Shapiro, Co-Founder, Non-Executive Director (Age 77)
  • Bernat Olle Ph.D., Venture Partner
  • Michael F. MacLean, Chief Financial Officer, Executive Vice President (Age 45)
  • Stephen Muniz, Executive Vice President - Legal, Finance and Operations
  • Eric Elenko, Executive Vice President - Science & Technology
  • David Steinberg, Executive Vice President - Company Creation
  • Joseph B. Bolen Ph.D., Chief Scientific Officer (Age 62)

How do I buy Puretech Health stock?

Shares of Puretech Health and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Puretech Health's stock price today?

One share of Puretech Health stock can currently be purchased for approximately GBX 170.85.

How big of a company is Puretech Health?

Puretech Health has a market capitalization of £404.57 million.

How can I contact Puretech Health?

Puretech Health's mailing address is 501 Boylston St Ste 6102, BOSTON, MA 02116-3769, United States. The company can be reached via phone at +1-617-4822333.


MarketBeat Community Rating for Puretech Health (PRTC)

Community Ranking:  4.0 out of 5 (star star star star)
Outperform Votes:  295 (Vote Outperform)
Underperform Votes:  72 (Vote Underperform)
Total Votes:  367
MarketBeat's community ratings are surveys of what our community members think about Puretech Health and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Puretech Health (LON:PRTC) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: GBX 260.20GBX 252.80GBX 242.80GBX 252.80

Puretech Health (LON:PRTC) Consensus Price Target History

Price Target History for Puretech Health (LON:PRTC)

Puretech Health (LON:PRTC) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
2/20/2018Peel HuntReiterated RatingBuyGBX 313View Rating Details
2/20/2018Numis SecuritiesReiterated RatingBuyGBX 259View Rating Details
1/26/2018Liberum CapitalReiterated RatingBuyGBX 248View Rating Details
11/30/2017N+1 SingerReiterated RatingBuyView Rating Details
11/17/2017Jefferies GroupReiterated RatingBuyView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Earnings History for Puretech Health (LON:PRTC)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Puretech Health (LON:PRTC) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Puretech Health (LON:PRTC)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Puretech Health (LON PRTC) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Puretech Health (LON:PRTC)

Puretech Health (LON PRTC) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/28/2016Scardino,Dame MarjorieInsiderBuy5,000GBX 135£6,750
10/26/2015Ito,JoichiInsiderBuy6,650GBX 149£9,908.50
10/9/2015Scardino,MarjorieInsiderBuy6,890GBX 126£8,681.40
9/28/2015Langer,RobertInsiderBuy7,200GBX 135£9,720
9/16/2015LaMattina,JohnInsiderBuy11,000GBX 146£16,060
9/10/2015LaMattina,JohnInsiderBuy5,492GBX 146£8,018.32
9/9/2015LaMattina,JohnInsiderBuy11,000GBX 147£16,170
9/4/2015LaMattina,JohnInsiderBuy11,000GBX 138£15,180
9/3/2015Scardino,MarjorieInsiderBuy10,000GBX 135£13,500
(Data available from 1/1/2013 forward)

Headlines

Puretech Health (LON PRTC) News Headlines

Source:
DateHeadline
Peel Hunt Reiterates Buy Rating for Puretech Health (PRTC)Peel Hunt Reiterates Buy Rating for Puretech Health (PRTC)
www.americanbankingnews.com - February 20 at 6:58 AM
Numis Securities Reiterates "Buy" Rating for Puretech Health (PRTC)Numis Securities Reiterates "Buy" Rating for Puretech Health (PRTC)
www.americanbankingnews.com - January 29 at 9:06 AM
Peel Hunt Increases Puretech Health (PRTC) Price Target to GBX 313Peel Hunt Increases Puretech Health (PRTC) Price Target to GBX 313
www.americanbankingnews.com - January 27 at 12:36 PM
Puretech Healths (PRTC) Buy Rating Reiterated at Liberum CapitalPuretech Health's (PRTC) Buy Rating Reiterated at Liberum Capital
www.americanbankingnews.com - January 27 at 12:36 PM
resTORbio Appoints Lynne Sullivan to Its Board of DirectorsresTORbio Appoints Lynne Sullivan to Its Board of Directors
finance.yahoo.com - January 3 at 9:34 AM
Puretech Health (PRTC) Earns Buy Rating from Peel HuntPuretech Health (PRTC) Earns Buy Rating from Peel Hunt
www.americanbankingnews.com - December 24 at 3:26 PM
Vedanta Biosciences Granted Four New U.S. Patents Expanding ... - Business Wire (press release)Vedanta Biosciences Granted Four New U.S. Patents Expanding ... - Business Wire (press release)
www.businesswire.com - December 13 at 4:46 PM
resTORbio Appoints Paul Fonteyne to Its Board of DirectorsresTORbio Appoints Paul Fonteyne to Its Board of Directors
finance.yahoo.com - December 11 at 11:01 AM
Why your doctor may soon have you playing video gamesWhy your doctor may soon have you playing video games
finance.yahoo.com - December 5 at 12:01 PM
PureTech Health Plc breached its 50 day moving average in a Bullish Manner : PRTC-GB : December 4, 2017PureTech Health Plc breached its 50 day moving average in a Bullish Manner : PRTC-GB : December 4, 2017
finance.yahoo.com - December 4 at 10:19 AM
Puretech Healths (PRTC) Buy Rating Reiterated at Peel HuntPuretech Health's (PRTC) Buy Rating Reiterated at Peel Hunt
www.americanbankingnews.com - December 1 at 12:28 AM
Puretech Healths (PRTC) "Buy" Rating Reiterated at N+1 SingerPuretech Health's (PRTC) "Buy" Rating Reiterated at N+1 Singer
www.americanbankingnews.com - November 30 at 11:02 PM
Liberum Capital Reiterates Buy Rating for Puretech Health (PRTC)Liberum Capital Reiterates Buy Rating for Puretech Health (PRTC)
www.americanbankingnews.com - November 30 at 9:42 PM
Numis Securities Raises Puretech Health (PRTC) Price Target to GBX 233Numis Securities Raises Puretech Health (PRTC) Price Target to GBX 233
www.americanbankingnews.com - November 30 at 7:34 PM
Peel Hunt Reiterates Buy Rating for Puretech Health PLC (PRTC)Peel Hunt Reiterates Buy Rating for Puretech Health PLC (PRTC)
www.americanbankingnews.com - November 21 at 12:16 AM
Puretech Health PLC (PRTC) Receives "Buy" Rating from Jefferies Group LLCPuretech Health PLC (PRTC) Receives "Buy" Rating from Jefferies Group LLC
www.americanbankingnews.com - November 18 at 1:38 PM
Should You Buy PureTech Health plc (LSE:PRTC)?Should You Buy PureTech Health plc (LSE:PRTC)?
finance.yahoo.com - November 18 at 11:03 AM
PureTech Health to Present at Jefferies 2017 Healthcare Conference in LondonPureTech Health to Present at Jefferies 2017 Healthcare Conference in London
finance.yahoo.com - November 9 at 11:57 AM
Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to Accelerate Development of VE303, a Novel Human ... - Business Wire (press release)Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to Accelerate Development of VE303, a Novel Human ... - Business Wire (press release)
www.businesswire.com - November 4 at 9:05 AM
Vedanta Biosciences Awarded Up To $5.4 Million from CARB-X to Accelerate Development of VE303, a Novel Human Microbiome-Derived Treatment for Serious Bacterial InfectionVedanta Biosciences Awarded Up To $5.4 Million from CARB-X to Accelerate Development of VE303, a Novel Human Microbiome-Derived Treatment for Serious Bacterial Infection
finance.yahoo.com - November 4 at 9:05 AM
Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live ... - Business Wire (press release)Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live ... - Business Wire (press release)
www.businesswire.com - November 1 at 7:42 AM
Vedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live Biotherapeutics that Induce CD8+ T CellsVedanta Biosciences to Advance Cancer Immunotherapy Candidates Based on Microbiome-Derived Live Biotherapeutics that Induce CD8+ T Cells
finance.yahoo.com - November 1 at 7:42 AM
PureTech Health plc (LSE:PRTC): How Does It Impact Your Portfolio?PureTech Health plc (LSE:PRTC): How Does It Impact Your Portfolio?
finance.yahoo.com - October 3 at 11:06 AM
Puretech Health PLC (PRTC) Stock Rating Reaffirmed by N+1 SingerPuretech Health PLC (PRTC) Stock Rating Reaffirmed by N+1 Singer
www.americanbankingnews.com - September 25 at 10:32 PM
PureTech Health Plc breached its 50 day moving average in a Bearish Manner : PRTC-GB : September 25, 2017PureTech Health Plc breached its 50 day moving average in a Bearish Manner : PRTC-GB : September 25, 2017
finance.yahoo.com - September 25 at 12:29 PM
Puretech Health PLC (PRTC) Earns Buy Rating from Numis Securities LtdPuretech Health PLC (PRTC) Earns Buy Rating from Numis Securities Ltd
www.americanbankingnews.com - September 25 at 7:22 AM
PureTech Health Notes US Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition ... - Business Wire (press release)PureTech Health Notes US Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition ... - Business Wire (press release)
www.businesswire.com - September 20 at 7:57 AM
PureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition from Human SpeechPureTech Health Notes U.S. Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition from Human Speech
finance.yahoo.com - September 20 at 7:57 AM
PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics ... - Business Wire (press release)PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics ... - Business Wire (press release)
www.businesswire.com - September 19 at 6:44 AM
PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small MoleculesPureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small Molecules
finance.yahoo.com - September 19 at 6:44 AM
PureTech Health Plc :PRTC-GB: Earnings Analysis: For the six months ended June 30, 2017 : September 6, 2017PureTech Health Plc :PRTC-GB: Earnings Analysis: For the six months ended June 30, 2017 : September 6, 2017
finance.yahoo.com - September 7 at 7:53 AM
Liberum Capital Reaffirms Buy Rating for Puretech Health PLC (PRTC)Liberum Capital Reaffirms Buy Rating for Puretech Health PLC (PRTC)
www.americanbankingnews.com - August 31 at 12:32 AM
Puretech Health PLC (PRTC) Rating Reiterated by Numis Securities LtdPuretech Health PLC (PRTC) Rating Reiterated by Numis Securities Ltd
www.americanbankingnews.com - August 30 at 10:34 PM
PureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic Biology - Business Wire (press release)PureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic Biology - Business Wire (press release)
www.businesswire.com - August 29 at 6:55 AM
PureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic BiologyPureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic Biology
finance.yahoo.com - August 29 at 6:55 AM
Puretech Health PLC (PRTC) to Release Quarterly Earnings on TuesdayPuretech Health PLC (PRTC) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - August 29 at 1:34 AM
PureTech Health Presents Data Supporting Treatment Approach for Interstitial Cystitis/Bladder Pain Syndrome Based on Novel Alivio Inflammation-Targeting TechnologyPureTech Health Presents Data Supporting Treatment Approach for Interstitial Cystitis/Bladder Pain Syndrome Based on Novel Alivio Inflammation-Targeting Technology
finance.yahoo.com - July 13 at 8:14 AM
Gelesis Announces Last Patient Out in the Pivotal Gelesis100 Weight-Loss StudyGelesis Announces Last Patient Out in the Pivotal Gelesis100 Weight-Loss Study
finance.yahoo.com - July 12 at 7:09 AM
PureTech Health Announces Initiation of Phase 2b mTORC1 Inhibitors Study in Elderly Patients at Increased Risk of ... - Business Wire (press release)PureTech Health Announces Initiation of Phase 2b mTORC1 Inhibitors Study in Elderly Patients at Increased Risk of ... - Business Wire (press release)
www.businesswire.com - May 11 at 8:30 AM
PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 ... - Business Wire (press release)PureTech Health Announces Licensing and Equity Agreement with Novartis to Advance Clinical Stage mTORC1 ... - Business Wire (press release)
www.businesswire.com - March 25 at 6:56 PM
PureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and StrategyPureTech Health Appoints Bharatt Chowrira, Ph.D., J.D., as President and Chief of Business and Strategy
uk.finance.yahoo.com - March 2 at 8:30 AM
PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference - Business Wire (press release)PureTech Health to Present at the Cowen and Company 37th Annual Health Care Conference - Business Wire (press release)
www.businesswire.com - February 25 at 1:39 AM
PureTech Health Appoints Atul Pande M.D., Former SVP at GlaxoSmithKline, as Chief Medical OfficerPureTech Health Appoints Atul Pande M.D., Former SVP at GlaxoSmithKline, as Chief Medical Officer
uk.finance.yahoo.com - February 23 at 8:49 AM
PureTech Health to Present at the Leerink Partners 6th Annual Global Healthcare ConferencePureTech Health to Present at the Leerink Partners 6th Annual Global Healthcare Conference
uk.finance.yahoo.com - February 7 at 8:47 AM
PureTech Health to Present at the Jefferies 2016 Healthcare Conference in LondonPureTech Health to Present at the Jefferies 2016 Healthcare Conference in London
uk.finance.yahoo.com - November 2 at 10:30 AM
Vedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial ConsortiaVedanta Biosciences Granted First European Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia
uk.finance.yahoo.com - October 19 at 3:26 PM
Half Year 2016 PureTech Health PLC Earnings Release - Time Not SuppliedHalf Year 2016 PureTech Health PLC Earnings Release - Time Not Supplied
biz.yahoo.com - September 7 at 10:25 AM
Vedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial ConsortiaVedanta Biosciences Granted U.S. Patent Broadly Covering Pharmaceutical Compositions for Microbiome Therapeutics Based on Bacterial Consortia
uk.finance.yahoo.com - August 16 at 10:10 AM

SEC Filings

Puretech Health (LON:PRTC) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Puretech Health (LON PRTC) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.